Setchell K D, Suchy F J, Welsh M B, Zimmer-Nechemias L, Heubi J, Balistreri W F
Mass Spectrometry Laboratory, Children's Hospital Medical Center, Cincinnati, Ohio 45229.
J Clin Invest. 1988 Dec;82(6):2148-57. doi: 10.1172/JCI113837.
A new inborn error in bile acid synthesis, manifest in identical infant twins as severe intrahepatic cholestasis, is described involving the delta 4-3-oxosteroid 5 beta-reductase catalyzed conversion of the key intermediates, 7 alpha-hydroxy-4-cholesten-3-one and 7 alpha,12 alpha-dihydroxy-4-cholesten-3-one for chenodeoxycholic and cholic acid synthesis, to the respective 3 alpha-hydroxy-5 beta (H) products. This defect was detected by fast atom bombardment ionization-mass spectrometry from an elevated excretion and predominance of taurine conjugated unsaturated hydroxy-oxo-bile acids. Gas chromatography-mass spectrometry confirmed these to be 7 alpha-hydroxy-3-oxo-4-cholenoic and 7 alpha,12 alpha-dihydroxy-3-oxo-4-cholenoic acids (75-92% of total). Fasting serum bile acid concentrations were greater than 37 mumol/liter; chenodeoxycholic acid was the major bile acid, but significant amounts of allo(5 alpha-H)-bile acids (approximately 30%) were present. Biliary bile acid concentration was less than 2 mumol/liter and consisted of chenodeoxycholic, allo-chenodeoxycholic, and allo-cholic acids. These biochemical findings, which were identical in both infants, indicate a defect in bile acid synthesis involving the conversion of the delta 4-3-oxo-C27 intermediates into the corresponding 3 alpha-hydroxy-5 beta(H)-structures, a reaction that is catalyzed by a delta 4-3-oxosteroid-5 beta reductase enzyme. This defect resulted in markedly reduced primary bile acid synthesis and concomitant accumulation of delta 4-3-oxo-and allo-bile acids. These findings indicate a pathway in bile acid synthesis whereby side chain oxidation can occur despite incomplete alterations to the steroid nucleus, and lend support for an active delta 4-3-oxosteroid 5 alpha-reductase catalyzing the conversion of the delta 4-3-oxosteroid intermediates to the respective 3 alpha-hydroxy-5 alpha(H)-structures.
本文描述了一种新的胆汁酸合成先天性缺陷,在一对同卵双胞胎婴儿中表现为严重的肝内胆汁淤积,该缺陷涉及δ4-3-氧代类固醇5β-还原酶催化关键中间体7α-羟基-4-胆甾烯-3-酮和7α,12α-二羟基-4-胆甾烯-3-酮转化为鹅去氧胆酸和胆酸合成所需的相应3α-羟基-5β(H)产物。通过快原子轰击电离质谱法检测到这种缺陷,表现为牛磺酸结合的不饱和羟基-氧代胆汁酸排泄增加且占主导地位。气相色谱-质谱法证实这些物质为7α-羟基-3-氧代-4-胆烯酸和7α,12α-二羟基-3-氧代-4-胆烯酸(占总量的75-92%)。空腹血清胆汁酸浓度大于37μmol/升;鹅去氧胆酸是主要的胆汁酸,但存在大量的别(5α-H)-胆汁酸(约30%)。胆汁中胆汁酸浓度小于2μmol/升,由鹅去氧胆酸、别-鹅去氧胆酸和别-胆酸组成。这两名婴儿的这些生化结果相同,表明胆汁酸合成存在缺陷,涉及δ4-3-氧代-C27中间体转化为相应的3α-羟基-5β(H)结构,该反应由δ4-3-氧代类固醇-5β还原酶催化。这种缺陷导致初级胆汁酸合成显著减少,并伴随δ4-3-氧代和别-胆汁酸的积累。这些发现表明了胆汁酸合成中的一条途径,即尽管类固醇核的改变不完全,侧链氧化仍可发生,并支持存在一种活性δ4-3-氧代类固醇5α-还原酶催化δ4-3-氧代类固醇中间体转化为相应的3α-羟基-5α(H)结构。